(Q53196730)

English

Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly.

scientific article published on 13 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Giacomo Cartenì

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Andrea Vecchione

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Graziella Pinotti

6

object named as

Graziella Pinotti

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

author name string

Laura Giannetta

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Giovanni Ucci

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Giorgio De Signoribus

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Antonio Contillo

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Giuseppe Pezzella

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Simona Orecchia

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Patrizia Beccaglia

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

OBI/EPO-ITA-01/1 study group

12

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

publication date

13 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

15

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

1057-1066

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

https://scigraph.springernature.com/pub.10.1007/s00520-007-0220-4

0 references

Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anemia in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing patient perceptions of the side effects of cancer chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The level of haemoglobin in anaemic cancer patients correlates positively with quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing quality of life in cancer patients: anemia and fatigue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of quality of life in a clinical trial with nonrandom dropout: the effect of epoetin alfa in anemic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of anemia in patients receiving chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17431689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-007-0220-4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17431689

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53196730&oldid=1768029944"